Viatris OTC business acquired by Cooper Consumer Health
Cooper Consumer Health acquired Viatris OTC business, an Europe consumer health / otc pharmaceuticals brand, on Jul 8, 2024.
Transaction summary
- Target
- Viatris OTC business
- Acquirer
- Cooper Consumer Health
- Seller
- Viatris
- Announced
- 2023-10-01
- Geography
- Europe
- Tags
- Consumerconsumer healthConsumer health / OTC pharmaceuticalsOTC medicinespharmaceutical manufacturing
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-06-19
- Latest update
- 2026-10-21
Value and multiples
100% enterprise value
EUR 1.9B
100% enterprise value | EUR
Basis: Public source
Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.
Approx. $2.1B USD using FX date 2023-09-29 at 1.0594 EUR/USD.
EV / revenue
-
Period: Undisclosed
Basis: Public source
EV / EBITDA
-
EBITDA basis not stated
Basis: Public source
Amounts paid and other reported values
Original reported amounts and bases; a stake payment is distinct from the estimated whole-company valuation.
Consideration: EUR 1.9B
Official Viatris Form 8-K: EUR 1.85 billion cash at closing plus up to EUR 100 million contingent cash consideration.
Basis
- Viatris’ Form 8-K of 3 July 2024 reports up to EUR 1.95bn in cash: EUR 1.85bn at closing plus up to EUR 100m of contingent consideration. The filing does not give revenue, EBITDA or a multiple for the business.
Source summary
France: Cooper Consumer Health completes acquisition of Viatris OTC business - Investors in Healthcare
ConfirmedViatris Form 8-K — completion of Cooper Consumer Health OTC divestiture
ConfirmedViatris disclosed up to EUR 1.95 billion cash consideration: EUR 1.85 billion at closing plus up to EUR 100 million contingent consideration.
Open sourceContinue your research
Related transaction comps
Merck Consumer Care acquired by Bayer
2014-05-06 · Confirmed
View transaction → consumer healthVitabiotics acquired by Bain Capital
2026-07-24 · Confirmed
View transaction → consumer healthKenvue acquired by Kimberly-Clark
2025-11-03 · Confirmed
View transaction → OTC medicinesLamisil acquired by Karo Healthcare
2023-08-01 · Confirmed
View transaction →